Ciprofloxacin in urinary tract infections.
The high in vitro activity of ciprofloxacin against most urinary tract pathogens and its favourable pharmacokinetics suggests considerable potential for use in therapy. The published controlled clinical trials show that ciprofloxacin has few adverse reactions and is at least as effective as the drugs with which it was compared.
Høiby
N
N
Statens Seruminstitut's Department of Clinical Microbiology Rigshospitalet, Copenhagen, Denmark.
D001419:Bacteria / Q000302:isolation & purification; D002939:Ciprofloxacin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D008297:Male; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D002939:Ciprofloxacin